Seewaldt and Buermeyer awarded grand prize from the Global Challenge to Prevent Breast Cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Victoria Seewaldt
Nancy Buermeyer
Michele Atlan

The Global Challenge to Prevent Breast Cancer has awarded:

  • The Grand Prize (Researcher Category) to Victoria Seewaldt, professor and chair of Population Sciences at City of Hope, who, with Chris Sistrunk of the SoCAL STEM and Community Outread Team, proposed STEM education to help prevent breast cancer.

  • The Grand Prize (Advocate Category) to Nancy Buermeyer, senior policy strategist at Breast Cancer Prevention Partners, who, with co-author Janet Nudelman, advocates reducing emissions at major ports to lower breast cancer risk.

  • In addition to the two Grand Prize winners chosen by a judging committee of experts and advocates, those in attendance and watching online also had their say, voting on an Audience Choice Award. The winner, Michele Atlan, vice president at the Breast Cancer Care and Research Fund, proposed a novel way to repackage natural ingredients to aid prevention efforts.

Started by the California Breast Cancer Research Program last fall, the Global Challenge was designed to uncover transformative prevention research ideas, and address the staggering statistic that, despite treatment advancements, people continue to be diagnosed with breast cancer at rates that have remained essentially unchanged over the past three decades.

Finalists were selected from dozens of applications that were submitted to the Global Challenge and competed at the Idea Showcase and Competition in San Francisco.

The ideas presented at the Global Challenge Idea Showcase and Competition will inform more than $15 million in funding that CBCRP will devote to breast cancer prevention research over the next five years.

YOU MAY BE INTERESTED IN

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
When it comes to fighting cancer today, collaboration is key. At a time when funding is uncertain, yet innovative breakthroughs are accelerating every day, it’s more important than ever for oncologists, scientists, academic researchers, and community physicians, to come together to share knowledge and gain insights about the forefront of cancer research.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login